Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States

  • Andrea Wang-Gillam
  • , William Schelman
  • , Stacey Ukrainskyj
  • , Caly Chien
  • , Martha Gonzalez
  • , Zhao Yang
  • , Marek Kania
  • , Heather Yeckes-Rodin

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science